HOTH

Hoth Therapeutics Inc

NASDAQ: HOTH · HEALTHCARE · BIOTECHNOLOGY

$0.66

-23.35% today

Updated 2026-06-05

Market cap

$12.62M

P/E ratio

—

P/S ratio

—

EPS (TTM)

$-0.90

Dividend yield

—

52W range

$0 – $2

Volume

10.0M

Market cap

$12.62M

P/E ratio

—

P/S ratio

—

EPS (TTM)

$-0.90

Dividend yield

—

52W range

$0 – $2

Volume

10.0M

WallStSmart proprietary scores

out of 100

Grade: F

Strong Sell

Investment rating

4.3

Growth

6.8

Quality

3.0

Profitability

5.0

Valuation

C+

1/9

Piotroski F-Score

Weak

—

Altman Z-Score

—

Industry rank

—

View all highly rated stocks (75+) →202 stocks currently score above 75

Price targets

Analyst target

$5.00

+657.69%

12-Month target

—

Intrinsic (DCF)

—

Margin of safety

—

Price chart

Stock snapshot

Strengths

+ Debt/equity 0.00x — low leverage

Risks

- Piotroski 1/9 — weak financial health

- Thin margins at 0.00%

- Negative free cash flow $-3.05M

Key financials

Revenue Net Income Free Cash Flow

Metric	2022	2023	2024	2025	TTM
Revenue	$0.00	$0.00	$0.00	$0.00	—
Net income	$-11.37M	$-7.85M	$-8.19M	$-12.47M	$-2.69M
EPS	—	—	—	—	$-0.90
Free cash flow	$-9.37M	$-8.45M	$-6.98M	$-9.80M	$-3.05M
Profit margin	—	—	—	—	—

Peer comparison

Company	Mkt Cap	Score	Growth	Profit	Value	Quality	MoS	Rating
HOTH	$12.62M	21	4.3	3.0	5.0	6.8	—	Avoid
LLY	$948.95B	78	10.0	10.0	5.0	6.0	—	Strong Buy
JNJ	$536.54B	59	4.7	9.0	3.3	6.0	-71.41%	Buy
ABBV	$380.57B	63	4.0	8.0	4.0	5.0	-55.64%	Buy
UNH	$343.21B	54	5.3	5.5	4.7	5.5	-26.61%	Buy
MRK	$285.64B	50	3.3	8.0	2.7	5.0	-49.34%	Hold

Smart narrative

Hoth Therapeutics Inc trades at $0.66. Our Smart Value Score of 21/100 indicates the stock is weak. The company scores 1/9 on the Piotroski F-Score.

Frequently asked questions

What is Hoth Therapeutics Inc's stock price?

Hoth Therapeutics Inc (HOTH) trades at $0.66.

Is Hoth Therapeutics Inc overvalued?

Hoth Therapeutics Inc carries a Smart Value Score of 21/100 (Grade F), which we rate Strong Sell. That score blends growth, quality, and valuation into one read.

What is the price target of Hoth Therapeutics Inc (HOTH)?

The 12-month analyst consensus target is $5.00, about 657.7% above the current $0.66. A consensus target is the average of Wall Street's 12-month forecasts, so it works as a sentiment gauge rather than a guarantee, and it resets with every earnings cycle.

Company info

SectorHEALTHCARE

IndustryBIOTECHNOLOGY

CountryUSA

ExchangeNASDAQ

CurrencyUSD

hoththerapeutics.com

Quick metrics

P/S ratio—

ROE-141.96%

Beta0.58

50D MA$0.80

200D MA$1.14

Shares out0.02B

Float0.02B

Short ratio—

Avg volume10.0M

Performance

1 week—

1 month—

3 months—

YTD—

1 year—

3 years—

5 years—

Compare

HOTH vs LLY →HOTH vs JNJ →HOTH vs ABBV →Stock screener →